“Explore how electronic records and signatures enhance GMP compliance in mRNA immunotherapy development. Learn about risk-based validation, data integrity, and training policies from quality and regulatory experts.”
Discover the important crossroads of GMP and electronic systems as they relate to mRNA immunotherapy development and manufacturing with insights from quality and regulatory consulting experts.
Validation of Electronic Systems on a Risk-Based Approach
Both quality and regulatory consulting firms encourage a risk-based approach for validating electronic systems. This includes evaluating the effects of electronic records and signatures on product quality and patient safety.
This allows the developers to catalogue (and ranked) risks and collaborate around what is important for the development team to validate, simply having them implement vs a high touch process of ensured compliance.
Full Validation Protocols
Validating electronic systems for mRNA immunotherapies in GMP requires strict validation protocols. Advisory companies walk developers through writing dense guidelines that outline proper operation of the system with consideration towards security and data integrity.
Validations of this nature are designed to help guarantee that electronic records or signatures will undergo the regulatory scrutiny when these are used, and they really provide for processing controls.
Security of Data Quality
Data integrity and security must be the priorities in electronic GMP systems. Quality and regulatory consulting firms help in setting new rules and laws that stop data manipulation, unauthorized access to the system, and make electronic records traceable.
For example, using encryption, access controls and audit trails to protect critical data.
Policies for Training and Documentation
Training and proper documentation are essential attributes to the compliance when implementing electronic records and signatures. Consulting firms offer advice on creating training to ensure that people know how to use electronic systems. Detailed documentation, that includes standard operating procedures (SOPs) is also necessary in order to prove compliance to regulators during inspections.
History/Data Validation & Compliance Reporting
Ideally, electronic systems create complete audit trails of all relevant actions. For example, developers work with quality and regulatory consulting firms to develop strong audit trail practices that allow a reconstructed record of those events. So this means clean audit trail for regulatory compliance reporting.
That step not only confirms to regulators that our systems (like electronic records and signatures) are compliant but also puts us on the right path to achieving electronically controlled, full digitalized manufacturing environment in compliance with requirements of GMP for mRNA immunotherapies.
Conclusion
Companies that specialize in quality and regulatory consulting are paramount when it comes to assisting developers with the intricacies of electronic systems integration. Consulting firms can support manufacturers to truly leverage the advantages of digitization while still fully complying with regulations.
Reach out to BioBoston Consulting today or check out our website to know more about how we can help you with your organization.
